AACR21: Bris­tol My­ers looks to build Op­di­vo's case in ear­ly can­cer with full da­ta in pre-sur­gi­cal NSCLC

Check­point in­hibitors have com­plete­ly changed the land­scape of metasta­t­ic, un­re­sectable can­cer since their in­tro­duc­tion. But one re­main­ing fron­tier is in pa­tients whose tu­mors can still …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER